Radial Flow Technology Promises Chromatography Improvements

Non-isotopic immunoassays, for all their increasing specificity and sensitivity, remain for biochemists some of the most labor-intensive operations in the clinical/diagnostic lab. The repetitive pipetting of sampies, dilutents, and reagents to and from microtiter plates not only ties up highly qualified staff in tedious procedures but also opens the door to mistakes—a situation ready made for automation. A degree of automation has already been achieved with systems such as the Biomek 10

Written byMike Spear
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Non-isotopic immunoassays, for all their increasing specificity and sensitivity, remain for biochemists some of the most labor-intensive operations in the clinical/diagnostic lab. The repetitive pipetting of sampies, dilutents, and reagents to and from microtiter plates not only ties up highly qualified staff in tedious procedures but also opens the door to mistakes—a situation ready made for automation.

A degree of automation has already been achieved with systems such as the Biomek 1000 from Beckman Instruments Inc. (see The Scientist, January 23, 1989, page 17) that can automatically pipette, dilute, and dispense samples and reagents, and photometrically read microtiter plates, all in one integrated package of instrumentation. But expected soon on the market are two single instruments that will give the same results and will offer immunologists a facility long enjoyed by their clinical biochemist colleagues, namely “random access” operation. Simply, what this means is the ability to load a single ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies